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Abstract
Background and aims: Open-access scheduling is highly utilized for facilitating generally low-risk endoscopies.
Preprocedural screening addresses sedation requirements; however, procedural safety may be compromised if screening is
inaccurate. We sought to determine the reliability of our open-access scheduling system for appropriate use of conscious
sedation.
Methods: We prospectively and consecutively enrolled outpatient procedures booked at an academic center by open-access
using screening after in-office gastroenterology (GI) consultation. We collected the cases inappropriately booked for con-
scious sedation and compared the characteristics for significant differences.
Results: A total of 8063 outpatients were scheduled for procedures with conscious sedation, and 5959 were booked with
open-access. Only 78 patients (0.97%, 78/8063) were identified as subsequently needing anesthesiologist-assisted sedation;
44 (56.4%, 44/78) were booked through open-access, of which chronic opioid (47.7%, 21/44) or benzodiazepine use (34.1%, 15/
44) were the most common reasons for needing anesthesiologist-assisted sedation. Patients on chronic benzodiazepines
required more midazolam than those not on chronic benzodiazepines (P¼ .03) of those patients who underwent conscious
sedation. Similarly, patients with chronic opioid use required more fentanyl than those without chronic opioid use (P¼ .04).
Advanced liver disease and alcohol use were common reasons for patients being booked after in-office consultation and
were significantly higher than those booked with open-access (both P< .01).
Conclusions: We observed that the majority of patients can be triaged for conscious sedation using a multi-tiered screening
process. Importantly, few patients (<1.0%) were inappropriately booked for conscious sedation. The most common reasons
for considering anesthesiologist-assisted sedation were chronic opioid, benzodiazepine and/or alcohol use and advanced
liver disease. This suggests that these entities could be included in screening processes for open-access scheduling.
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Introduction
Colon cancer is the second leading cause of cancer deaths in the
United States with a case-fatality rate of roughly one in three
[1]. Fortunately, colonoscopy is a well-established measure for
colorectal cancer screening and is recommended for all patients
aged 50 years [2–4]. Traditionally, in-office consultation pre-
ceded colonoscopy to determine if it was indicated. With grow-
ing demand for colonoscopy, open-access scheduling is now
utilized to facilitate endoscopy for common indications includ-
ing colon cancer screening, thereby removing potential access
barriers for these common and generally low-risk tests [5].
A recent guideline by the American Society for
Gastrointestinal Endoscopy (ASGE) on open-access endoscopy
highlights several safety issues regarding open-access schedul-
ing. Specifically, the authors raise concerns regarding the ap-
propriateness of referral, suggesting that in-office consultation
should be obtained if either indication or safety is in question
[5]. In a recent review, authors outlined four common preproce-
dural safety considerations in open-access scheduling including
management of anticoagulation and platelet agents, indications
for prophylactic antibiotic drug use, management of poor bowel
preparation, and need for anesthesiology-assisted sedation [6].
Many open-access centers use a screening questionnaire to en-
sure that these issues are adequately addressed. Despite these
screening practices, inaccuracies still remain at the time of en-
doscopy that could impact the safety of the procedure regarding
the appropriate sedation needed [7].
The American Society of Anesthesiology (ASA) defines con-
scious or moderate sedation as providing anxiolysis and anal-
gesia while maintaining a patent airway, spontaneous
ventilation and cardiac function [8]. This type of sedation is an
important component of endoscopic evaluation as it may be ad-
ministered by non-anesthesiologists. A nationwide survey dem-
onstrated that 98% of endoscopists in the United States
regularly use conscious sedation during their procedures [9].
While sedation improves both endoscopic examination and
overall patient satisfaction, appropriate anesthesia remains
problematic as it increases procedural costs and, importantly,
has inherit risks to patient safety if not used appropriately
[10,11]. The ASGE, ASA and American Gastroenterology
Association have developed sedation practice guidelines to
highlight the importance of optimizing patient safety. These
guidelines outline preprocedural evaluation that emphasizes
close review of medical history, medications, overall comorbid-
ity risk assessment (i.e. ASA classification) and completing a
focused physical exam including airway classification using the
Mallampati scoring system [8]. Patients deemed to be low-risk
can typically receive conscious sedation; otherwise, they will re-
quire anesthesiologist-assisted sedation or monitored anesthe-
sia care (MAC) [8,12,13]. When a patient is not appropriately
identified as requiring anesthesiologist-assisted sedation prior
to a procedure, a long wait time may occur while anesthesia ser-
vice is being coordinated, or the procedure may have to be can-
celled, thus generating patient dissatisfaction.
We perform >23 000 procedures a year at our institution,
and we use an open-access scheduling system that is available
to those in our network. We currently utilize a multi-tiered
screening process that includes a-web-based requisition form,
telephone interview by a trained scheduler, and educational
patient material to identify patients who may need
anesthesiology-assisted sedation. We completed a prospective
study aimed to audit the safety of our scheduling practices and
determine the reliability of our open-access triage system for
conscious sedation versus anesthesiologist-assisted sedation.
Methods
We prospectively and consecutively enrolled all outpatient pro-
cedures booked at the general gastrointestinal (GI) endoscopy
suite at Beth Israel Deaconess Medical Center (BIDMC) in Boston
between March 2014 and September 2014. Institutional Review
Board approval at BIDMC was obtained prior to initiation of this
study.
Our procedure log was obtained from our online medical
system and clinical booking software available at BIDMC. All
procedures were completed by attending staff gastroenterolo-
gists or accredited training fellows supervised by staff gastro-
enterologists. At BIDMC, advanced procedures (including but
not limited to endoscopic retrograde cholangiopancreatography
and endoscopic ultrasound) are performed in a separate unit
and were therefore excluded from this study. Conscious sed-
ation, consisting of intravenous doses of fentanyl for analgesia
and midazolam for anxiolysis, was administered by a trained
registered nurse under the supervision of a staff attending
gastroenterologist. Anesthesiologist-assisted sedation required
the presence of a staff attending anesthesiologist.
Procedures were split into two categories: (1) patients booked
through open-access scheduling and (2) patients booked after
in-office consultation with an attending staff gastroenterologist.
Open-access scheduling at BIDMC occurs either via an online
requisition form through our web-based portal or via a brief
phone interview with the patient by a trained scheduler (as
determined by the referring physician). Samples of the web-
based requisition form and questionnaire used by our sched-
ulers are supplied in Figure 1 and Table 1, respectively. Using
this system, the patient’s medical history is reviewed and in-
cludes obstructive sleep apnea, chronic kidney disease and
morbid obesity as well as medication lists (particularly anti-
coagulants and antiplatelet agents). Patients who pass the
screen are then booked for an endoscopic procedure with con-
scious sedation with a staff gastroenterologist. Patients also re-
ceive preparation instructions, which also outline screening
questions, to ensure that they are given appropriate bowel prep-
aration and are booked for the appropriate level of sedation.
Sample instructions are provided in Figure 2.
Upon arrival at the BIDMC endoscopy suite, the final screen-
ing occurs for appropriateness of conscious sedation.
Specifically, patients are interviewed and admitted by nursing
staff, who review the patient’s full past medical, social and
family histories along with medications and medication aller-
gies with consideration of the ASGE guidelines for
anesthesiologist-assisted sedation (Table 2). When available,
previous procedures are also reviewed with a focus on the
amount of medications given during the last procedure and if
there were any procedural complications or difficulties.
After the above assessment, if the nursing staff is concerned
about a patient’s suitability for conscious sedation, the staff
gastroenterologist is then notified and assesses the patient.
When appropriate, an anesthesia consult is obtained for pa-
tients needing to be upgraded to anesthesiologist-assisted sed-
ation. If available, the procedure is completed the same day;
otherwise, it is rescheduled for a different day.
We collected patient characteristics from the nursing assess-
ment as well as the patient’s online medical record including
age, sex, body mass index (BMI), co-morbidities as listed under
their medical history, opioid and benzodiazepine use,
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information on prior procedures and ASA classification on pa-
tients thought to be incorrectly assigned for conscious sedation.
The approximate delay in the scheduled procedure for these pa-
tients was calculated by taking the difference between the
scheduled procedure time and the start time of the delayed pro-
cedure as noted in the nursing notes. Patients were listed as
using benzodiazepines and/or opioids chronically if there was
daily use for >6 months and/or if these medications were listed
on intake medication lists at the time of the procedure.
Similarly, patients who drank alcohol daily for >6 months and/
or had “alcoholism,” “alcohol abuse,” “alcohol withdrawal,” or
“alcoholic cirrhosis” recorded in their past medical history were
listed as using alcohol chronically.
We used Fisher’s test to determine if there were statistically
significant differences in patient characteristics between pa-
tients booked by open-access scheduling and those seen in con-
sultation prior to procedure. A t test was used to compare
medication doses given during conscious sedation in patients
with and without chronic opioid and/or benzodiazepines use.
Results
During the study period, 8063 outpatient procedures were
scheduled with conscious sedation, of which 5102 (63.3%) were
colonoscopies, 2620 (32.5%) were upper endoscopies, 332 (4.1%)
were sigmoidoscopies, and the remainder (0.1%) were small
bowel enteroscopies. In addition, 434 patients who failed the
screening tools during this period were also scheduled with an-
esthesiologist-assisted sedation. These patients failed the initial
screening due to advanced ASA class (III-IV), presence of ob-
structive sleep apnea, high risk for obstructive sleep apnea
(BMI> 40), and/or presence of chronic kidney disease. Of the
8063 outpatient procedures, 5959 procedures (73.9%) were
booked for conscious sedation using our open-access schedul-
ing system (Figure 3).
After intake nursing assessment, 78 patients (0.97%, 78/8063)
were identified as potentially needing anesthesiologist-assisted
sedation. Of these 78 patients, 44 patients (56.4%) were booked
through open-access-scheduling and made up a small percentage
of all patients booked using open-access scheduling (0.74%, 44/
5959) (Figure 3). Females made up 52% (41/78) of the population,
and the mean age was 60.4 years (range: 22–94 years). The me-
dian BMI of the 78 patients was 27 kg/m2 (range: 20.0–57.4 kg/m2).
The most common reasons cited by our intake nurses for
needing anesthesiologist-assisted sedation were chronic opi-
oid use (47.7%, 21/44) and chronic benzodiazepine use (34.1%,
15/44). Other reasons for anesthesiologist-assisted sedation
are listed in Table 3. The majority of these patients felt to be
inappropriately scheduled for conscious sedation were ASA
classification II. Nine (20.5%) patients had an ASA classifica-
tion  III, 5 of the 9 patients had congestive heart failure
and/or chronic pulmonary disease requiring oxygen
supplementation.
After secondary review by the staff gastroenterologist, al-
most all (42) of the 44 patients completed their indicated pro-
cedure on the same day (95.5%). However, two patients had
their procedures cancelled because anesthesiologist-assisted
sedation was not available on the given day. Of the remaining
42 patients, 27 received anesthesiologist-assisted sedation,
while 15 patients received conscious sedation because they had
refused to reschedule their procedures with anesthesia and an
anesthesiologist was not available. On further review, seven of
the 15 patients (46.7%) who received conscious sedation used
opioids chronically and required significantly more fentanyl
during the procedure than those without opioid use (n¼ 8) (me-
dian fentanyl use: 250 vs 75 micrograms, P¼ 0.04). Moreover, 4
Figure 1. Open-access endoscopy Gastrointestinal Order Form
Table 1. Sample questions asked by a trained telephone scheduler
Have you been diagnosed with sleep apnea with the recommenda-
tion to use a CPAP/BIPAP machine at home?
Are you taking any blood thinning medications?
Is your current weight over 300 pounds?
Do you have any kidney-related problems?
CPAP: continuous positive airway pressure; BIPAP: Bi-level positive airway
pressure
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patients (26.7%) with chronic benzodiazepine use received con-
scious sedation and required significantly more midazolam
than those without chronic benzodiazepine use (n¼ 11) (median
midazolam use: 7 vs 2.5 milligrams, P¼ 0.03). In patients requir-
ing anesthesiologist-assisted sedation, the average wait time
was 123 minutes (range: 14–362 minutes).
There were 34 patients (43.6%, 34/78) booked for procedures,
after an in-office GI consultation, who were felt to be inappro-
priate for conscious sedation at the time of their procedure.
This group represented 1.6% of the patients (34/2104) booked
after in-office consultation. Of these, 15 patients used opioids
chronically (44.1%), and 16 patients used benzodiazepines
chronically (47.1%). There was no statistical significance when
comparing these subgroups with those booked using open-
access scheduling with chronic opioid and benzodiazepine use
(Table 3). Additionally, 12 patients had advanced liver disease
(35.2%), and 11 patients used alcohol chronically (32.3%), which
was significantly higher than patients booked by open-access
(P< 0.01). Upon review of the in-office consultation notes, there
was no documentation about the type of sedation the patient
might have required for the procedure.
In two patients, the procedure was aborted after attempting
conscious sedation. Both of these patients were seen by a GI
provider prior to their procedure. One of the two patients was
undergoing upper endoscopy and became combative after
receiving 6 milligrams of midazolam and 200 micrograms of
fentanyl. She carried a diagnosis of alcoholic cirrhosis and used
opioids chronically. The other patient had a colonoscopy, which
was aborted because of increased pain despite receiving 10
milligrams of midazolam and 300 micrograms of fentanyl. The
patient had chronic anxiety requiring use of benzodiazepines.
Discussion
In this prospective study, we observed that the vast majority of pa-
tients can be safely and efficiently triaged for conscious sedation
in a high-volume, tertiary care center using a multi-tiered screen-
ing process. Importantly, very few patients (< 1.0%) were in-
appropriately booked for conscious sedation, and this proportion
does not appear to be different from booking with open-access
scheduling or after GI office consultation. While the majority of
patients thought to be unsuitable for conscious sedation under-
went anesthesiologist-assisted sedation on the same day, these
patients suffered longer wait times, and two patients needed to be
rescheduled to a different day.
An additional important finding was that the most common
reasons for patients being identified as requiring anesthesiologist-
assisted sedation were chronic opioid and benzodiazepine and/or
chronic alcohol use and a history of advanced liver disease.
Moreover, those patients on chronic opioids or benzodiazepines
who received conscious sedation required significantly higher
doses of medication than those without chronic use. Also, in the
group of patients booked after in-office consultation, there were
more patients identified as requiring anesthesiologist-assisted sed-
ation with chronic alcohol use and advanced liver disease, many
of whom were referred from our large hepatology and transplant
practices and by gastroenterologists who do not perform
procedures.
Figure 2. Sample patient information provided on the preparation packet
Table 2. Considerations for anesthesiologist-assisted sedation
ASA class III or higher
History of intolerance or with allergies/adverse reaction to standard
sedatives
Patients undergoing prolonged procedure requiring deep sedation
such as endoscopic mucosal resection or dilatations
Patients at increased risk for airway obstruction (i.e. Mallampati
grade III or IV or history of obstructive sleep apnea requiring noc-
turnal positive airway pressure ventilation)
Acutely agitated or uncooperative patients
Patients on opioids, hypnotics or sedatives
Patients with dementia, sleep apnea, morbid obesity (BMI> 40 with-
out medical problems or BMI >35 with medical problems)
ASA: American Society of Anesthesiology; BMI: body mass index
Figure 3. Flowchart of procedural scheduling between March and September
2014
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Expert opinion suggests that patients who habitually use
opioids, benzodiazepines and alcohol may not be appropriate
candidates for conscious sedation [6]. Therefore, the screening
forms for patients with chronic use of benzodiazepines, opioids
and heavy alcohol use may need modification to better alert
providers considering anesthesiologist-assisted sedation.
Adding advanced liver disease to the preprocedure screening
may also further limit inappropriately booked conscious-
sedation cases. Studies like the one presented focus on improv-
ing patient safety and remain a cornerstone in healthcare
quality [14]. In response to our findings, we adjusted our open-
access initial screening tools to capture patients on chronic opi-
oids and benzodiazepines (Figure 4).
Limitations of our study include the descriptive nature and
single-center study design. Additionally, while the identifica-
tion process was robust and fully integrated into the workflow
of the endoscopy unit, it is possible to have missed cases that
would have underestimated the number of inappropriately
booked cases. Moreover, we do not have data on alcohol, benzo-
diazepine and opioid use on all patients who had procedures
during the study period as a comparison group. Lastly, we did
not assess intra-procedure patient comfort to assess the validity
of our nursing intake screen in cases completed with conscious
sedation despite concern for inappropriate booking.
In conclusion, we found that the rates of cases booked in-
appropriately for conscious sedation are exceedingly low in a
high-volume, tertiary-care endoscopy center using a multi-
tiered screening process. Moreover, this descriptive study fur-
ther asserts that open-access endoscopy remains a safe practice
when robust and thorough screening tools are used at the time
of booking.
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